Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Before investing in 2023, it's vital to learn key concepts. Equip yourself with knowledge to ensure smart investment choices.
17,856 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Berkshire Hathaway disclosed a new stake in Macy’s in its Q1 2026 13F, a small starter position that contrasts with p...
Berkshire Hathaway's Greg Abel recently bought Macy's stock, sparking questions about value and strategy. This in-dep...
Rocket Lab just hit a new speed record with its Victus Haze mission, signaling potential shifts in the space-launch m...
A prominent wall street tech analyst says Micron could soar fourfold if AI infrastructure spending remains robust thr...
Robinhood's Vlad Tenev signals a pivot for crypto toward tokenized real-world assets, stepping away from meme coins a...
As America reshapes its manufacturing landscape, rare earths play a pivotal role in magnets, EVs, and wind turbines. ...
Retirees entering assisted living often discover a gap in coverage: original medicare pays toward only short-term med...
A fresh framework shows a simple trio of ETFs may match the glide-path goals of target-date funds for those planning ...
When a chief operating officer sells stock, investors take notice. This article breaks down the implications, explain...
A new Nasdaq-100 strategy fund began paying weekly Friday distributions, targeting a 40% yield and challenging the tr...
In July 2026, certain Social Security recipients will see two SSI payments in one month due to the calendar. The Augu...